Prostate Cancer
Research

Volume 1 Number 2
February 2013

Home > Disciplines > Publications > Prostate Cancer Research > Volume 1, Year 2013 > Number 2, February

CONTENTS

▼

DIAGNOSIS
EPIDEMIOLOGY, RISK FACTORS, PREVENTION
ETIOLOGY, PATHOGENESIS, PATHOLOGY
FOLLOW-UP, QUALITY OF LIFE
PROGNOSIS
TREATMENT

DIAGNOSIS

▲

.

Drazer MW, Huo D, Schonberg MA, Razmaria A, Eggener SE.
Population-based patterns and predictors of prostate-specific antigen screening among older men in the United States.
J Clin Oncol. 2011 May 1;29(13):1736-43. doi: 10.1200/JCO.2010.31.9004. Epub 2011 Mar 28.
Source | Full text | Similar articles

Wu LM, Xu JR, Gu HY, Hua J, Zhu J, Chen J, Zhang W, Hu J.
Role of magnetic resonance imaging in the detection of local prostate cancer recurrence after external beam radiotherapy and radical prostatectomy.
Clin Oncol (R Coll Radiol). 2013 Apr;25(4):252-64. doi: 10.1016/j.clon.2012.11.010. Epub 2013 Jan 11.
Source | Full text | Similar articles

EPIDEMIOLOGY, RISK FACTORS, PREVENTION

▲

.

Hemminki K, Ji J, Försti A, Sundquist J, Lenner P.
Concordance of survival in family members with prostate cancer.
J Clin Oncol. 2008 Apr 1;26(10):1705-9. doi: 10.1200/JCO.2007.13.3355.
Source | Full text | Similar articles

.

Thompson IM, Pauler Ankerst D, Chi C, Goodman PJ, Tangen CM, Lippman SM, Lucia MS, Parnes HL, Coltman CA Jr.
Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial.
J Clin Oncol. 2007 Jul 20;25(21):3076-81. DOI: 10.1200/JCO.2006.07.6836
Source | Full text | Similar articles

ETIOLOGY, PATHOGENESIS, PATHOLOGY

▲

.

Hassan S, Karpova Y, Baiz D, Yancey D, Pullikuth A, Flores A, Register T, Cline JM, D'Agostino R Jr, Danial N, Datta SR, Kulik G.
Behavioral stress accelerates prostate cancer development in mice.
J Clin Invest. 2013 Feb 1;123(2):874-86. doi: 10.1172/JCI63324. Epub 2013 Jan 25.
Source | Full text | Similar articles

.

Wu C, Aronson WJ, Terris MK, Presti JC Jr, Kane CJ, Amling CL, Freedland SJ.
Diabetes predicts metastasis after radical prostatectomy in obese men: results from the SEARCH database.
BJU Int. 2013 Jan 10. doi: 10.1111/j.1464-410X.2012.11687.x. [Epub ahead of print]
Source | Full text | Similar articles

FOLLOW-UP, QUALITY OF LIFE

▲

.

Alibhai SM, Duong-Hua M, Sutradhar R, Fleshner NE, Warde P, Cheung AM, Paszat LF.
Impact of androgen deprivation therapy on cardiovascular disease and diabetes.
J Clin Oncol. 2009 Jul 20;27(21):3452-8. doi: 10.1200/JCO.2008.20.0923. Epub 2009 Jun 8.
Source | Full text | Similar articles

.

Parekh A, Chen MH, Hoffman KE, Choueiri TK, Hu JC, Bennett CL, Kattan MW, Sartor O, Stein K, Graham PL, D'Amico AV, Nguyen PL.
Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone.
Urology. 2013 Jan;81(1):130-4. doi: 10.1016/j.urology.2012.08.068.
Source | Full text | Similar articles

.

Sato Y, Tanda H, Nakajima H, Nitta T, Akagashi K, Hanzawa T, Tobe M, Haga K, Uchida K, Honma I.
Dissociation between patients and their partners in expectations for sexual life after radical prostatectomy.
Int J Urol. 2013 Mar;20(3):322-8. doi: 10.1111/iju.12022. Epub 2013 Jan 8.
Source | Full text | Similar articles

PROGNOSIS

▲

.

Agoua NG, Vian E, Dumoulin M, Blanchet P.
[Salvage radiotherapy outcomes for biochemical recurrence following radical prostatectomy among the African-Caribbean population of Guadeloupe].
Prog Urol. 2013 Feb;23(2):128-36. doi: 10.1016/j.purol.2012.09.007. Epub 2012 Oct 22. French.
Source | Full text | Similar articles

.

Brenner H, Arndt V.
Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: population-based estimates for the year 2000 by period analysis.
J Clin Oncol. 2005 Jan 20;23(3):441-7. DOI: 10.1200/JCO.2005.11.148. Epub 2004 Nov 30.
Source | Full text | Similar articles

.

Cooperberg MR, Cowan JE, Hilton JF, Reese AC, Zaid HB, Porten SP, Shinohara K, Meng MV, Greene KL, Carroll PR.
Outcomes of active surveillance for men with intermediate-risk prostate cancer.
J Clin Oncol. 2011 Jan 10;29(2):228-34. doi: 10.1200/JCO.2010.31.4252. Epub 2010 Nov 29.
Source | Full text | Similar articles

.

D'Amico AV, Chen MH, Roehl KA, Catalona WJ.
Identifying patients at risk for significant versus clinically insignificant postoperative prostate-specific antigen failure.
J Clin Oncol. 2005 Aug 1;23(22):4975-9. DOI: 10.1200/JCO.2005.08.904
Source | Full text | Similar articles

.

Ginzburg S, Nevers T, Staff I, Tortora J, Champagne A, Kesler SS, Laudone VP, Wagner JR.
Prostate cancer biochemical recurrence rates after robotic-assisted laparoscopic radical prostatectomy.
JSLS. 2012 Jul-Sep;16(3):443-50. doi: 10.4293/108680812X13462882736538.
Source | Full text | Similar articles

.

Huang JG, Pedersen J, Hong MK, Harewood LM, Peters J, Costello AJ, Hovens CM, Corcoran NM.
Presence or absence of a positive pathological margin outperforms any other margin-associated variable in predicting clinically relevant biochemical recurrence in Gleason 7 prostate cancer.
BJU Int. 2013 May;111(6):921-7. doi: 10.1111/j.1464-410X.2012.11665.x. Epub 2013 Jan 25.
Source | Full text | Similar articles

.

Kinoshita H, Shimizu Y, Mizowaki T, Takayama K, Norihisa Y, Kamoto T, Kamba T, Hayashino Y, Hiraoka M, Ogawa O.
Risk factors predicting the outcome of salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy.
Int J Urol. 2013 Jan 8. doi: 10.1111/iju.12049. [Epub ahead of print]
Source | Full text | Similar articles

.

Mitsuzuka K, Narita S, Koie T, Kaiho Y, Tsuchiya N, Yoneyama T, Kakoi N, Kawamura S, Tochigi T, Habuchi T, Ohyama C, Arai Y.
Pathological and biochemical outcomes after radical prostatectomy in men with low-risk prostate cancer meeting the Prostate Cancer International: Active Surveillance criteria.
BJU Int. 2013 May;111(6):914-20. doi: 10.1111/j.1464-410X.2012.11658.x. Epub 2013 Jan 15.
Source | Full text | Similar articles

.

Murtola TJ, Kujala PM, Tammela TL.
High-grade prostate cancer and biochemical recurrence after radical prostatectomy among men using 5α-reductase inhibitors and alpha-blockers.
Prostate. 2013 Jan 17. doi: 10.1002/pros.22638. [Epub ahead of print]
Source | Full text | Similar articles

.

Patel DA, Presti JC Jr, McNeal JE, Gill H, Brooks JD, King CR.
Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy.
J Clin Oncol. 2005 Sep 1;23(25):6157-62. DOI: 10.1200/JCO.2005.01.2336
Source | Full text | Similar articles

.

Ro YK, Lee S, Jeong CW, Hong SK, Byun SS, Lee SE.
Biochemical recurrence in Gleason score 7 prostate cancer in korean men: significance of the primary Gleason grade.
Korean J Urol. 2012 Dec;53(12):826-9. doi: 10.4111/kju.2012.53.12.826. Epub 2012 Dec 20.
Source | Full text | Similar articles

.

Stark JR, Perner S, Stampfer MJ, Sinnott JA, Finn S, Eisenstein AS, Ma J, Fiorentino M, Kurth T, Loda M, Giovannucci EL, Rubin MA, Mucci LA.
Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?
J Clin Oncol. 2009 Jul 20;27(21):3459-64. doi: 10.1200/JCO.2008.20.4669. Epub 2009 May 11.
Source | Full text | Similar articles

.

Stephenson AJ, Scardino PT, Eastham JA, Bianco FJ Jr, Dotan ZA, DiBlasio CJ, Reuther A, Klein EA, Kattan MW.
Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.
J Clin Oncol. 2005 Oct 1;23(28):7005-12. DOI: 10.1200/JCO.2005.01.867
Source | Full text | Similar articles

.

Stewart AJ, Scher HI, Chen MH, McLeod DG, Carroll PR, Moul JW, D'Amico AV.
Prostate-specific antigen nadir and cancer-specific mortality following hormonal therapy for prostate-specific antigen failure.
J Clin Oncol. 2005 Sep 20;23(27):6556-60.
Source | Full text | Similar articles

.

Walz J, Gallina A, Saad F, Montorsi F, Perrotte P, Shariat SF, Jeldres C, Graefen M, Bénard F, McCormack M, Valiquette L, Karakiewicz PI.
A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer.
J Clin Oncol. 2007 Aug 20;25(24):3576-81.
Source | Full text | Similar articles

.

Zhou P, Chen MH, McLeod D, Carroll PR, Moul JW, D'Amico AV.
Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy.
J Clin Oncol. 2005 Oct 1;23(28):6992-8. DOI: 10.1200/JCO.2005.01.2906
Source | Full text | Similar articles

TREATMENT

▲

.

Boike TP, Lotan Y, Cho LC, Brindle J, DeRose P, Xie XJ, Yan J, Foster R, Pistenmaa D, Perkins A, Cooley S, Timmerman R.
Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer.
J Clin Oncol. 2011 May 20;29(15):2020-6. doi: 10.1200/JCO.2010.31.4377. Epub 2011 Apr 4.
Source | Full text | Similar articles

.

Dale W, Hemmerich J, Bylow K, Mohile S, Mullaney M, Stadler WM.
Patient anxiety about prostate cancer independently predicts early initiation of androgen deprivation therapy for biochemical cancer recurrence in older men: a prospective cohort study.
J Clin Oncol. 2009 Apr 1;27(10):1557-63. doi: 10.1200/JCO.2008.18.5850. Epub 2009 Mar 2.
Source | Full text | Similar articles

.

Muller RL, Presti JC Jr, Aronson WJ, Terris MK, Kane CJ, Amling CL, Freedland SJ.
Does salvage radiation therapy change the biology of recurrent prostate cancer based on PSA doubling times? Results from the SEARCH database.
Urology. 2012 May;79(5):1105-10. doi: 10.1016/j.urology.2012.01.034. Epub 2012 Mar 23.
Source | Full text | Similar articles

.

Tosoian JJ, Trock BJ, Landis P, Feng Z, Epstein JI, Partin AW, Walsh PC, Carter HB.
Active surveillance program for prostate cancer: an update of the Johns Hopkins experience.
J Clin Oncol. 2011 Jun 1;29(16):2185-90. doi: 10.1200/JCO.2010.32.8112. Epub 2011 Apr 4.
Source | Full text | Similar articles

bottom

▲